Graduate program in Precision Medicine with a concentration in multi-omic technology for therapeutic development.

JADBIO, automates the use of state-of-the-art algorithms in Machine Learning, with initial applications inspired by data analysis problems in biomedicine. We manage the challenges of over-estimating and overfitting even with the complex data and limited sample sizes associated with multi-omics data.

BRIDGenomics is a group of industry professionals dedicated to making a difference in healthcare through genomics. We help bridge the gap between diagnostic, pharmaceutical, and research sectors in the field of genomics. I am proud to be part of our dynamic team, with vast experience in genomics and a track record of not only meeting, but exceeding our clients expectations.

This is an exciting dual role in which I mesh with two teams. I strengthen and build our clinical network in collaboration with our Managing Director. I also connect organizations who develop cancer directed therapeutics and diagnostics with Indivumed products and services

Indivumed's IndivuType platform, addresses the most critical challenges in cancer data analysis: confidence! The unique quality of the IndivuType platform starts in the surgery suite, with strong clinical partners and SOPs that limit ischemia time and guarantee the most complete set of multi-omics data possible: whole genome, whole transcriptome, miRNA, proteome, phospho-proteome from both cancer and normal adjacent tissue. We complement the deep molecular data with comprehensive and longitudinal clinical profiles. The quality control on all sides of the data instills the greatest confidence as our customer/partners validate drug targets and identify new biomarkers.

Working with Bluebee colleagues in North America and in our headquarters in Europe to introduce Bluebee's unique private cloud-based accelerated genomics analysis platform. We enable secure, fast, scalable, efficient and affordable processing of Next Generation Sequencing data for our customer partners and for individual organizations.

Responsible for introducing strategic clinical labs to QIAGEN's unique bioinformatics offerings in support of next generation sequencing analysis, interpretation, and reporting.

Collaborate across business areas to deliver key bioinformatics product in support of global NGS initiatives.

In 2008, as NGS became the dominant method of generating sequence data, CLC Bio introduced the Genomics Workbench, a revolutionary tool that enabled biologists to analyze their sequencing data on standard compute resources leveraging strong visualizations and a friendly user interface. CLC bio quickly became the leading bioinformatics solution provider with a focus on Next Generation Sequencing. In addition to the desktop applications, CLC bio added enterprise solutions with options for command-line access for the advanced users impressed by the efficiency of the algorithms and workflows. CLC Bio's applications are comprehensive, cross-platform, and can analyze and visualize genomic, transcriptomic, and epigenomic data from all major Next Generation Sequencing platforms. I had the privilege of evangelizing the CLC bio NGS portfolio from the beginning until the acquisition by QIAGEN. Our enterprise customers included the largest pharmaceutical companies and the smallest universities. We provided great products with great service, and under the QIAGEN flag, CLC bio is still advancing the analysis of genomic data across the globe.

Global responsibility for support of prospective and existing customer base. Built customer happiness through on site training, tutorials, and trouble shooting. Provided all technical sales activities, including specification for custom development.

Translating customer needs into product specifications.

Creation of nucleic acid based core facilities, including, synthesis of standard and special oligonucleotides, Sanger-based automated sequencing, and management of core facility personnel. Also developed SOPs for the handling and storage of reagents for clinical use.

Directed DNA synthesis and DNA sequencing core facilities in Oncology

Nucleic Acid Synthesis